The <scp>PINNACLE</scp> study: A multicentre phase <scp>II</scp> trial of nilotinib in combination with pegylated interferon‐α2b in newly diagnosed chronic phase chronic myeloid leukaemiaDavid T. Yeung, the Australasian Leukaemia and Lymphoma Group, John Reynolds et al.|British Journal of Haematology|2025Cited by 1